Enovis Quarterly Balance Sheet
NYSE: ENOVHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Enovis financial position
As of Jul 3, 2026, Enovis reported total assets of $3.77 billion, down 25.0% from a year earlier against total liabilities of $2.29 billion. Shareholders' equity stood at $1.48 billion, or 39.2% of assets. The company held $12.6 million in cash and equivalents against $1.28 billion of debt, a net debt position of $1.27 billion.
The current ratio (current assets divided by current liabilities) was 1.98, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.87.
Summary generated from market data by MetaCap's automated system. Methodology
Enovis balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-07-03 | Q1 20262026-04-03 | Q4 20252025-12-31 | Q3 20252025-10-03 | Q2 20252025-07-04 | Q1 20252025-04-04 | Q4 20242024-12-31 | Q3 20242024-09-27 | Q2 20242024-06-28 | Q1 20242024-03-29 | Q4 20232023-12-31 | Q3 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.56M | 33.13M | 36.39M | 33.62M | 44.07M | 38.46M | 48.17M | 35.42M | 35.00M | 66.27M | 36.19M | 32.13M |
| Receivables | 441.85M | 444.21M | 442.79M | 431.77M | 453.70M | 435.62M | 407.03M | 400.22M | 394.74M | 381.05M | 291.48M | 277.03M |
| Inventory | 601.66M | 602.54M | 584.38M | 613.75M | 628.22M | 585.91M | 547.12M | 609.66M | 615.04M | 586.00M | 468.83M | 470.91M |
| Total Current Assets | 1.21B | 1.24B | 1.21B | 1.28B | 1.28B | 1.22B | 1.15B | 1.20B | 1.17B | 1.15B | 896.52M | 854.19M |
| Property, Plant & Equipment | 527.53M | 519.72M | 507.06M | 486.42M | 460.13M | 426.29M | 404.50M | 403.25M | 378.45M | 345.70M | 270.80M | 260.19M |
| Goodwill | 709.85M | 711.90M | 718.30M | 1.22B | 1.78B | 1.73B | 1.69B | 2.39B | 2.35B | 2.41B | 2.06B | 2.03B |
| Intangible Assets | 1.15B | 1.19B | 1.24B | 1.28B | 1.34B | 1.34B | 1.32B | 1.40B | 1.38B | 1.41B | 1.13B | 1.10B |
| Total Assets | 3.77B | 3.83B | 3.83B | 4.43B | 5.02B | 4.88B | 4.72B | 5.55B | 5.44B | 5.48B | 4.51B | 4.40B |
| Accounts Payable | 194.47M | 213.62M | 187.53M | 198.78M | 212.02M | 188.15M | 179.10M | 158.04M | 159.83M | 155.75M | 132.47M | 125.06M |
| Short-Term Debt | 37.39M | 35.00M | 35.00M | 20.00M | 20.03M | 20.03M | 20.03M | 20.03M | 15.03M | 20.10M | 0 | 0 |
| Total Current Liabilities | 612.05M | 608.66M | 598.47M | 575.44M | 568.18M | 477.42M | 529.00M | 530.22M | 518.00M | 549.13M | 369.61M | 355.28M |
| Long-Term Debt | 1.25B | 1.29B | 1.26B | 1.34B | 1.37B | 1.37B | 1.31B | 1.33B | 1.33B | 1.32B | 466.16M | 395.00M |
| Total Liabilities | 2.29B | 2.35B | 2.34B | 2.41B | 2.44B | 2.25B | 2.15B | 2.22B | 2.15B | 2.17B | 1.09B | 959.18M |
| Shareholders' Equity | 1.48B | 1.48B | 1.49B | 2.02B | 2.58B | 2.62B | 2.56B | 3.33B | 3.29B | 3.31B | 3.42B | 3.44B |
| Retained Earnings | -1.48B | -1.48B | -1.47B | -946.87M | -375.73M | -338.99M | -283.02M | 420.31M | 451.83M | 470.47M | 542.47M | 539.51M |
| Total Debt | 1.28B | 1.33B | 1.30B | 1.36B | 1.39B | 1.39B | 1.33B | 1.35B | 1.34B | 1.34B | 466.16M | 395.00M |
| Net Cash (Debt) | -1.27B | -1.29B | -1.26B | -1.33B | -1.35B | -1.35B | -1.28B | -1.31B | -1.31B | -1.27B | -429.97M | -362.87M |
| Shares Outstanding | 57.67M | 57.55M | 57.19M | 57.19M | 57.16M | 57.12M | 55.88M | 55.87M | 54.87M | 54.84M | 54.60M | 54.56M |
This table shows 12 quarterly periods of Enovis's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ENOV's reporting calendar. What is a balance sheet?